Inventor · disambiguated record
Stefan Trentmann
Also filed as: TRENTMANN STEFAN
9 granted patents·6 pending applications·66 citations·filing 2008–2020
88Inventor score
Top patents by PatentIndex Score
15 records- 0190US9051382B2Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding suchTRENTMANN STEFAN·Filed 2011·Granted Jun 9, 2015·26 cites·13 claims
- 0287US10898545B2Tear lipocalin muteins binding IL-4 r alphaASTRAZENECA AB·Filed 2019·Granted Jan 26, 2021·2 cites·15 claims
- 0387US9687524B2Tear lipocalin muteins binding IL-4 R alphaPIERIS PHARMACEUTICALS GMBH·Filed 2015·Granted Jun 27, 2017·6 cites·7 claims
- 0485US8986951B2Tear lipocalin in muteins binding IL-4 R alphaHOHLBAUM ANDREAS·Filed 2011·Granted Mar 24, 2015·13 cites·21 claims
- 0583US10232014B2Tear lipocalin muteins binding IL-4 R alphaPIERIS PHARMACEUTICALS GMBH·Filed 2017·Granted Mar 19, 2019·3 cites·25 claims
- 0683US9212208B2Muteins with tear lipocalin having affinity to human c-Met receptor tyrosine kinase and methods for obtaining the sameMATSCHINER GABRIELE·Filed 2009·Granted Dec 15, 2015·6 cites·22 claims
- 0782US9950034B2Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulationPIERIS PHARMACEUTICALS GMBH·Filed 2017·Granted Apr 24, 2018·3 cites·20 claims
- 0882US9610356B2Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulationPIERIS PHARMACEUTICALS GMBH·Filed 2012·Granted Apr 4, 2017·7 cites·23 claims
- 0972US2021196788A1Tear lipocalin muteins binding il-4 r alphaASTRAZENECA AB·Filed 2020·Application pending·0 cites
- 1056US2009274623A1In vivo imaging agents for met receptor tyrosine kinaseGEN ELECTRIC·Filed 2008·Application pending·0 cites
- 1155US2018311311A1Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulationPIERIS PHARMACEUTICALS GMBH·Filed 2018·Application pending·0 cites
- 1252US2017369542A1Human neutrophil gelatinase-associated lipocalin (hngal) muteins that bind hepcidin and nucleic acid encoding suchPIERIS PHARMACEUTICALS GMBH·Filed 2017·Application pending·0 cites
- 1349US9751920B2Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the samePIERIS PHARMACEUTICALS GMBH·Filed 2015·Granted Sep 5, 2017·0 cites·2 claims
- 1448US2015369821A1Novel lipocalin-mutein assays for measuring hepcidin concentrationPIERIS AG·Filed 2014·Application pending·0 cites
- 1546US2015291675A1Human neutrophil gelatinase-associated lipocalin (hngal) muteins that bind hepcidin and nucleic acid encoding suchPIERIS AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefan Trentmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →